BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1204 related articles for article (PubMed ID: 17402879)

  • 1. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
    Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
    J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can we increase phosphate removal with conventional hemodialysis?].
    Albalate M; Fernández C; López MD; Gago C; Jarraiz A; Pulido A; González A; Santana H; Hernando P; Gazapo RM; Caramelo C
    Nefrologia; 2003; 23(6):520-7. PubMed ID: 15002787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
    Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
    G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
    Schiffl H
    Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring hemodialysis dose with ionic dialisance in on-line hemodiafiltration].
    Maduell F; Puchades MJ; Navarro V; Torregrosa E; Rius A; Sánchez JJ
    Nefrologia; 2005; 25(5):521-6. PubMed ID: 16392302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
    Sombolos KI; Bamichas GI; Christidou FN; Gionanlis LD; Karagianni AC; Anagnostopoulos TC; Natse TA
    Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels].
    Tuccillo S; Bellizzi V; Catapano F; Di Iorio B; Esposito L; Giannattasio P; Maione E; Mangiacapra S; Minutolo R; Zamboli P; Conte G; De Nicola L
    G Ital Nefrol; 2002; 19(4):439-45. PubMed ID: 12369047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
    Mandolfo S; Borlandelli S; Imbasciati E; Badalamenti S; Graziani G; Sereni L; Varesani M; Wratten ML; Corsi A; Elli A
    Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorus dynamics during hemodialysis.
    Kjellstrand CM; Ing TS; Kjellstrand PT; Odar-Cederlof I; Lagg CR
    Hemodial Int; 2011 Apr; 15(2):226-33. PubMed ID: 21352467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.